IKT DCF Valuation - Inhibikase Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.58 USD -5.95% Market Closed

Market Cap: $191.6m

	Inhibikase Therapeutics Inc NASDAQ:IKT	US
	Albemarle Corp NYSE:ALB	US
	Cryoport Inc NASDAQ:CYRX	US
D	Dimand Societe Anonyme for The Use and Construction of Real Estate Constructions Services and Participations ATHEX:DIMAND	GR
N	Nippon Seiro Co Ltd TSE:5010	JP
	Palla Pharma Ltd ASX:PAL	AU
	ABVC Biopharma Inc NASDAQ:ABVC	US
Y	YPF SA BCBA:YPFD	AR
A	Arcis Resources Corp OTC:ARCS	US
	Nomura Holdings Inc TSE:8604	JP
N	Neuraxis Inc AMEX:NRXS	US
S	Suzhou Jinhongshun Auto Parts Co Ltd SSE:603922	CN

IKT's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.